ClinicalTrials.gg
RecruitingNCT05831904Updated Jun 22, 2023

Effect of Vibration Therapy on Hip Girdle Muscles in Healthy People

An interventional study of whole-body vibration in Hip Dislocation, sponsored by Seoul National University Hospital. Recruiting at 1 site in Korea, Republic of. Open to participants aged 5 Years to 15 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-06-22.

Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by May 2024, 2 years 5 months ago, but the record still lists the study as recruiting.
  • Started Jun 2023; still recruiting 3 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
5 Years to 15 Years
Sex
All
01

Study summary

This clinical trial(prospective, pilot study) is to learn about the effect of whole-body vibration on hip girdle muscles in healthy children as a primary study aiming for a new clinical intervention protocol to prevent hip dislocation in patients with severe cerebral palsy.

Read the detailed description

Design: Prospective, pilot study Setting: hospital rehabilitation department Intervention: Participants will be asked to walk and jump with a surface electromyography(EMG) attached to their hip girdle muscles. After the participants are positioned(standing) on the platform of whole-body vibration device, the study practitioner will record the sEMG values from the hip girdle muscles during the vibration applied. The mean values of repeating the same process with different vibrations applications and the values before vibration will be compared by using the SPSS using the paired "t-test" or Wilcoxon signed rank test for comparison between before and after vibration in the same group.

02

Conditions studied

  • Hip Dislocation

Browse trials for

03

In context

Hip Dislocation

107 studies on the registry are indexed under Hip Dislocation; 36 are open to participants now.

This study's planned enrollment of 20 is below the median of 86 across 64 interventional studies indexed under Hip Dislocation.

Browse Hip Dislocation studies →

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,900 studies on the registry; 274 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy children (5 to 15 years old)

Exclusion criteria

Exclusion Criteria:

  • Children with cerebral palsy, muscle paralysis, developmental or congenital hip joint abnormalities
  • Children who underwent hip joint surgery
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    20 healthy children

    20 healthy children aged 5 to 15 years , without any congenital or developmental abnormalities of their hip joint

    Device: whole-body vibration

Interventions

  • Devicewhole-body vibration

    After attaching the surface electromyography(EMG) to bilateral hip girdle muscles, participants will walk and jump at their comfortable speed. After investigator record the muscle activation values, participants will be asked to stand on the vibration device. While the whole-body vibration is applied, the hip girdle muscles activation values will be recorded accordingly via sEMG.

06

What researchers measure

Primary outcomes

  1. muscle activation values on surface electromyography(sEMG)

    surface muscle contraction of bilateral hip girdle muscles bilateral gluteus medius, tensor fascia lata, iliopsoas, rectus femoris muscles

    Time frame: 10 seconds for each session

Secondary outcomes

  1. VAS (Visual Analogue Scale)

    a psychometric scale that is generally used in pain scale surveys and this study participants will be asked to scale the uncomfortable feelings during the vibration

    Time frame: 10 seconds for each session

07

Study locations

1 of 1 sites recruiting
  • Department of Rehabilitation Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine
    Seongnam-si, Gyeonggi-do 463-707, Korea, Republic of
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2023 (actual). Primary completion is estimated for May 2024, 11 months after the start.

Of 32 interventional studies with no phase under Hip Dislocation, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 18. This study's planned 11 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 16, 2023
First posted
Apr 26, 2023
StartActual
Jun 1, 2023
Primary completionEst.
May 30, 2024
CompletionEst.
May 30, 2024
Last update
Jun 22, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05831904
Responsible party
Ju Seok Ryu (Professor, Seoul National University Hospital) — Principal investigator
First posted
Apr 26, 2023
Start date
Jun 1, 2023
Primary completion
May 30, 2024 (estimated)
Completion
May 30, 2024 (estimated)
Last update
Jun 22, 2023

Study contacts

Ju Seok Ryu, M.D. PhD
Contact
jseok337@snu.ac.kr
+82-31-787-7739
Ju Seok Ryu, M.D. PhD
study director · Seoul National University Bundang Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion